PARKINSONS DISEASE WITH DEMENTIA
Clinical trials for PARKINSONS DISEASE WITH DEMENTIA explained in plain language.
Never miss a new study
Get alerted when new PARKINSONS DISEASE WITH DEMENTIA trials appear
Sign up with your email to follow new studies for PARKINSONS DISEASE WITH DEMENTIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer drug shows promise for Parkinson's in small trial
Disease control CompletedThis Phase 2 study tested whether low doses of nilotinib, a drug already approved for leukemia, are safe and affect brain markers in 75 people with Parkinson's disease. Participants took either a placebo or one of two low doses of nilotinib daily for 12 months. The goal was to se…
Matched conditions: PARKINSONS DISEASE WITH DEMENTIA
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Ultrasound zaps brain barrier in Parkinson's dementia – first safety results in
Knowledge-focused CompletedThis study tested whether a focused ultrasound device can safely and temporarily open the blood-brain barrier in 20 people with mild-to-moderate Parkinson's disease dementia. The goal was to see if the procedure is safe and feasible, not to treat the disease itself. Researchers m…
Matched conditions: PARKINSONS DISEASE WITH DEMENTIA
Phase: NA • Sponsor: InSightec • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC